Innovative Swept Source for next generation OCT devices
According to the World Health Organization, 50% of all cases of blindness in Europe are preventable and 80% of all vision impairment is considered avoidable. However, early diagnostic requires comprehensive and accurate diagnosis...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
PLEC2022-009214
Dispositivo fotónico portátil para el diagnóstico de enferme...
586K€
Cerrado
EQC2019-006306-P
ACTUALIZACIÓN DE EQUIPAMIENTOS DE ALTA TECNOLOGIA PARA LA PL...
135K€
Cerrado
BES-2015-072197
TECNOLOGIAS DE IMAGEN OPTICA Y MODELOS OPTO-BIOMECANICOS PAR...
93K€
Cerrado
BIOPSYPEN
OPTICAL BIOPSY PEN A COMPACT AND LOW COST DIAGNOSTIC TOOL F...
5M€
Cerrado
ODYSSEUS
Ophtalmic Device for eYe StructureS Examination with Ultrahi...
150K€
Cerrado
Información proyecto ISSO
Duración del proyecto: 5 meses
Fecha Inicio: 2019-07-29
Fecha Fin: 2019-12-31
Líder del proyecto
OCTLIGHT APS
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
71K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
According to the World Health Organization, 50% of all cases of blindness in Europe are preventable and 80% of all vision impairment is considered avoidable. However, early diagnostic requires comprehensive and accurate diagnosis tools. While OCT has emerged over the past two decades as the undisputed gold standard for accurate, high resolution local characterization of ophthalmic tissues, its limitation to provide wide field-of-views (FOV) over the entire eye structures has been vastly acknowledge as a key bottleneck to improve early diagnosis of eye conditions – in particular retinal vascular diseases (e.g. diabetic retinopathy).
OCTLIGHT has developed a disruptive laser source – the heart of the OCT system – enabling a step improvement over competing alternatives in the market, providing the cornerstone towards the next generation of 3-dimensional, wide-field and high-resolution imaging of the eye. Besides its superior performance compared to current competitive technology, OCTL’s swept source delivers these advantages at a competitive price, providing an unmatched value proposition– not only in ophthalmic applications but also in other fields using OCT (e.g. cardiology, dermatology, etc.).
Resonating with the fast expansion of the OCT market - expected to reach $1.8Bn by 2024 and growing at a double-digit rate – there is thus a very significant business opportunity for OCTLIGHT to gain a foothold as the lead (sub-)supplier of top tier OCT components. Hereto, the successful implementation of the present innovation project will represent a significant business opportunity for OCTLIGHT, with significant revenue/profit and job creation to be untapped in the first 5 years of commercialization. In addition, the present project is considered as a vital cornerstone to fuel OCTLIGHT’s growth, while simultaneously providing tailwind to a step performance improvement in next generation OCT systems.